These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 37225096)

  • 21. Per- and Polyfluoroalkyl Substances and Hormone Levels During the Menopausal Transition.
    Harlow SD; Hood MM; Ding N; Mukherjee B; Calafat AM; Randolph JF; Gold EB; Park SK
    J Clin Endocrinol Metab; 2021 Oct; 106(11):e4427-e4437. PubMed ID: 34181018
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prenatal exposure to per- and polyfluoroalkyl substances (PFAS) and associations with attention-deficit/hyperactivity disorder and autism spectrum disorder in children.
    Skogheim TS; Weyde KVF; Aase H; Engel SM; Surén P; Øie MG; Biele G; Reichborn-Kjennerud T; Brantsæter AL; Haug LS; Sabaredzovic A; Auyeung B; Villanger GD
    Environ Res; 2021 Nov; 202():111692. PubMed ID: 34293314
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Exposure to per- and polyfluoroalkyl substances in early pregnancy and risk of cerebral palsy in children.
    Vilhelmsson A; Rylander L; Jöud A; Lindh CH; Mattsson K; Liew Z; Guo P; Ritz B; Källén K; Thacher JD
    Sci Total Environ; 2023 Nov; 899():165622. PubMed ID: 37474063
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Exposure to Per- and Polyfluoroalkyl Substances and Adiposity at Age 12 Years: Evaluating Periods of Susceptibility.
    Liu Y; Li N; Papandonatos GD; Calafat AM; Eaton CB; Kelsey KT; Chen A; Lanphear BP; Cecil KM; Kalkwarf HJ; Yolton K; Braun JM
    Environ Sci Technol; 2020 Dec; 54(24):16039-16049. PubMed ID: 33269902
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Exposure to perfluoroalkyl substances (PFAS) and association with thyroid hormones in adolescent males.
    Freire C; Vela-Soria F; Castiello F; Salamanca-Fernández E; Quesada-Jiménez R; López-Alados MC; Fernandez MF; Olea N
    Int J Hyg Environ Health; 2023 Jul; 252():114219. PubMed ID: 37451108
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exposure to Per- and Polyfluoroalkyl Substances and Timing of Puberty in Norwegian Boys: Data from the Bergen Growth Study 2.
    Forthun IH; Roelants M; Knutsen HK; Haug LS; Iszatt N; Schell LM; Jugessur A; Bjerknes R; Oehme NB; Madsen A; Bruserud IS; Juliusson PB
    Environ Sci Technol; 2024 Sep; 58(37):16336-16346. PubMed ID: 39226441
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Associations of Prenatal Per- and Polyfluoroalkyl Substance (PFAS) Exposures with Offspring Adiposity and Body Composition at 16-20 Years of Age: Project Viva.
    Zhang M; Rifas-Shiman SL; Aris IM; Fleisch AF; Lin PD; Nichols AR; Oken E; Hivert MF
    Environ Health Perspect; 2023 Dec; 131(12):127002. PubMed ID: 38054701
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Higher free thyroxine associated with PFAS exposure in first trimester. The Odense Child Cohort.
    Jensen RC; Glintborg D; Timmermann CAG; Nielsen F; Boye H; Madsen JB; Bilenberg N; Grandjean P; Jensen TK; Andersen MS
    Environ Res; 2022 Sep; 212(Pt D):113492. PubMed ID: 35597289
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association between per- and polyfluoroalkyl substances exposure and prevalence of chronic obstructive pulmonary disease: The mediating role of serum albumin.
    Wang Y; Zhang J; Zhang J; Hou M; Kong L; Lin X; Xu J; Yan C; Lin F; Ke S
    Sci Total Environ; 2024 May; 925():171742. PubMed ID: 38494022
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prenatal exposures to per- and polyfluoroalkyl substances and epigenetic aging in umbilical cord blood: The Healthy Start study.
    Niemiec SS; Kechris K; Pattee J; Yang IV; Adgate JL; Calafat AM; Dabelea D; Starling AP
    Environ Res; 2023 Aug; 231(Pt 2):116215. PubMed ID: 37224946
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Early-Life Exposure to Perfluoroalkyl Substances and Childhood Metabolic Function.
    Fleisch AF; Rifas-Shiman SL; Mora AM; Calafat AM; Ye X; Luttmann-Gibson H; Gillman MW; Oken E; Sagiv SK
    Environ Health Perspect; 2017 Mar; 125(3):481-487. PubMed ID: 27586368
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of perfluoroalkyl and polyfluoroalkyl substances with sex hormones in children and adolescents 6-19 Years of age.
    He Y; Hu C; Zhang Y; Fan X; Gao W; Fang J; Wang Y; Xu Y; Jin L
    Environ Pollut; 2023 Jul; 329():121707. PubMed ID: 37098366
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of perfluoroalkyl substances exposure in utero with reproductive hormone levels in cord blood in the Hokkaido Study on Environment and Children's Health.
    Itoh S; Araki A; Mitsui T; Miyashita C; Goudarzi H; Sasaki S; Cho K; Nakazawa H; Iwasaki Y; Shinohara N; Nonomura K; Kishi R
    Environ Int; 2016 Sep; 94():51-59. PubMed ID: 27209000
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prenatal exposure to perfluoroalkyl substances and associations with symptoms of attention-deficit/hyperactivity disorder and cognitive functions in preschool children.
    Skogheim TS; Villanger GD; Weyde KVF; Engel SM; Surén P; Øie MG; Skogan AH; Biele G; Zeiner P; Øvergaard KR; Haug LS; Sabaredzovic A; Aase H
    Int J Hyg Environ Health; 2020 Jan; 223(1):80-92. PubMed ID: 31653559
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prenatal and Childhood Per- and Polyfluoroalkyl Substance (PFAS) Exposures and Blood Pressure Trajectories From Birth to Late Adolescence in a Prospective US Prebirth Cohort.
    Zhang M; Aris IM; Lin PD; Rifas-Shiman SL; Brady TM; James-Todd T; Oken E; Hivert MF
    J Am Heart Assoc; 2023 Sep; 12(17):e030760. PubMed ID: 37642023
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prenatal perfluoroalkyl substances exposure and maternal sex steroid hormones across pregnancy.
    Rivera-Núñez Z; Kinkade CW; Khoury L; Brunner J; Murphy H; Wang C; Kannan K; Miller RK; O'Connor TG; Barrett ES
    Environ Res; 2023 Mar; 220():115233. PubMed ID: 36621543
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Perfluoroalkyl Substances during Pregnancy and Offspring Weight and Adiposity at Birth: Examining Mediation by Maternal Fasting Glucose in the Healthy Start Study.
    Starling AP; Adgate JL; Hamman RF; Kechris K; Calafat AM; Ye X; Dabelea D
    Environ Health Perspect; 2017 Jun; 125(6):067016. PubMed ID: 28669937
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasma per- and polyfluoroalkyl substance mixtures during pregnancy and duration of breastfeeding in the New Hampshire birth cohort study.
    Romano ME; Gallagher LG; Price G; Crawford KA; Criswell R; Baker E; Botelho JC; Calafat AM; Karagas MR
    Int J Hyg Environ Health; 2024 May; 258():114359. PubMed ID: 38521049
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plasma Concentrations of Per- and Polyfluoroalkyl Substances and Body Composition From Mid-Childhood to Early Adolescence.
    Janis JA; Rifas-Shiman SL; Seshasayee SM; Sagiv S; Calafat AM; Gold DR; Coull BA; Rosen CJ; Oken E; Fleisch AF
    J Clin Endocrinol Metab; 2021 Aug; 106(9):e3760-e3770. PubMed ID: 33740056
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Perfluoroalkyl Substances and Incident Natural Menopause in Midlife Women: The Mediating Role of Sex Hormones.
    Ding N; Harlow SD; Randolph JF; Mukherjee B; Batterman S; Gold EB; Park SK
    Am J Epidemiol; 2022 Jun; 191(7):1212-1223. PubMed ID: 35292812
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.